| Nov 22 |
AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
|
| Nov 21 |
Major companies that are also popular short-selling stocks
|
| Nov 21 |
Is Bristol Myers Squibb Stock a Buy?
|
| Nov 21 |
Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
|
| Nov 19 |
Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)
|
| Nov 19 |
Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
|
| Nov 18 |
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
|
| Nov 18 |
Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?
|
| Nov 18 |
EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer
|
| Nov 17 |
Bristol-Myers Squibb: Buy This Bargain Before It's Gone
|
